Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Other Working Capital Changes (2022 - 2026)

Genelux (GNLX) posted Other Working Capital Changes of -$87000.0 for Q1 2026, up 6.45% on a QoQ basis from -$93000.0 in Q4 2025, and down 150.88% year-over-year from $171000.0 in Q1 2025.

Analysis

Genelux (GNLX) Other Working Capital Changes (2022 - 2026) Analysis & Trends

Genelux has reported Other Working Capital Changes for 5 years, with the latest figure at -$87000.0 in Q1 2026.

  • On a quarterly basis, Other Working Capital Changes fell 150.88% year-over-year to -$87000.0 in Q1 2026; TTM through Mar 2026 was -$595000.0, a 43.06% increase from a year earlier, with the FY2025 full-year figure at -$337000.0, up 48.23% from the prior year.
  • Other Working Capital Changes was -$87000.0 for Q1 2026 at Genelux, up from -$93000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $5.5 million in Q1 2022, with the low at -$1.2 million in Q4 2024.
  • Average Other Working Capital Changes over 5 years is $264800.0, with a median of -$87000.0 recorded in 2026.
  • The largest YoY upside for Other Working Capital Changes was 630.12% in 2024 against a maximum downside of 1225.0% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $110000.0 in 2022, then tumbled by 183.64% to -$92000.0 in 2023, then plunged by 1225.0% to -$1.2 million in 2024, then surged by 92.37% to -$93000.0 in 2025, then grew by 6.45% to -$87000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$87000.0 (Q1 2026), -$93000.0 (Q4 2025), and -$834000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Genelux 108.17 Mn 108.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -87,000.00
Mar 31, 2026 -87,000.00
Dec 31, 2025 -93,000.00
Dec 31, 2025 -93,000.00
Sep 30, 2025 -834,000.00
Sep 30, 2025 -834,000.00
Jun 30, 2025 419,000.00
Jun 30, 2025 419,000.00
Mar 31, 2025 171,000.00
Mar 31, 2025 171,000.00
Dec 31, 2024 -1.22 Mn
Dec 31, 2024 -1.22 Mn
Sep 30, 2024 880,000.00
Sep 30, 2024 880,000.00
Jun 30, 2024 -877,000.00
Jun 30, 2024 -877,000.00
Mar 31, 2024 565,000.00
Mar 31, 2024 565,000.00
Dec 31, 2023 -92,000.00
Dec 31, 2023 -92,000.00